Also trades as: PRN.TO (TSX) · $vol 0M
PROF NASDAQ
Profound Medical Corp.
1W: +1.4%
1M: -14.4%
3M: -20.8%
YTD: -23.8%
1Y: +18.2%
3Y: -39.2%
5Y: -61.0%
$5.84
-0.01 (-0.17%)
Weekly Expected Move ±7.9%
$5
$5
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-03-07
Earliest Filing
2025-03-07
Latest Filing
partner: 1
Counterparties (Filed by PROF)
1 relationshipsCompanies named in PROF's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Siemens Healthineers | — | partner | entered into non-exclusive collaboration to expand access to TULSA procedure | 2025-03-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-04 | Regulation FD; Exhibits | View | |
| 2026-09-03 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-08-17 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-08-17 | Regulation FD; Exhibits | View | |
| 2026-08-13 | Regulation FD; Exhibits | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-07-24 | Regulation FD; Exhibits | View | |
| 2026-07-16 | Regulation FD; Exhibits | View | |
| 2026-07-15 | Regulation FD; Exhibits | View | |
| 2026-05-15 | Shareholder Vote; Exhibits | View | |
| 2026-05-14 | Regulation FD; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-16 | Regulation FD; Exhibits | View | |
| 2026-04-14 | Regulation FD; Exhibits | View | |
| 2026-04-01 | Regulation FD; Exhibits | View | |
| 2026-03-27 | Regulation FD; Exhibits | View | |
| 2026-03-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-10 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-03-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR